4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid has been researched along with tretazicar in 1 studies
| Studies (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Trials (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Recent Studies (post-2010) (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Studies (tretazicar) | Trials (tretazicar) | Recent Studies (post-2010) (tretazicar) |
|---|---|---|---|---|---|
| 21 | 5 | 5 | 205 | 6 | 42 |
| Protein | Taxonomy | 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid (IC50) | tretazicar (IC50) |
|---|---|---|---|
| Nitroreductase A | Escherichia coli O157:H7 | 0.89 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedlos, F; Marais, R; Schepelmann, S; Spooner, R | 1 |
1 other study(ies) available for 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid and tretazicar
| Article | Year |
|---|---|
Methods to improve efficacy in suicide gene therapy approaches: targeting prodrug-activating enzymes carboxypeptidase G2 and nitroreductase to different subcellular compartments.
Topics: Antineoplastic Agents; Aziridines; Bystander Effect; Cell Survival; Female; gamma-Glutamyl Hydrolase; Genes, Transgenic, Suicide; Genetic Therapy; Glutamates; Humans; Nitrogen Mustard Compounds; Nitroreductases; Ovarian Neoplasms; Prodrugs; Subcellular Fractions; Transfection; Tumor Cells, Cultured | 2004 |